Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism S1PRs modulators(Sphingosine 1-phosphate receptors modulators), Immunosuppressants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Preclinical | United States | 30 Oct 2020 | |
| Asthma | Preclinical | United States | 18 Apr 2019 |





